Bg Medicine Inc (BGMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,160 | -13,839 | -9,352 | -5,610 | -16,130 |
| Depreciation Amortization | 540 | 414 | 277 | 140 | 750 |
| Accounts receivable | -508 | 98 | -161 | 267 | N/A |
| Other Working Capital | 620 | 350 | -288 | 44 | -5,040 |
| Other Operating Activity | 5,098 | 3,532 | 2,376 | 1,185 | 2,450 |
| Operating Cash Flow | $-11,410 | $-9,445 | $-7,148 | $-3,974 | $-17,970 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -59 | -9 | N/A | -690 |
| Purchase Of Investment | -598 | -598 | -600 | -600 | N/A |
| Sale Of Investment | 2,650 | 2,650 | 2,250 | 1,250 | N/A |
| Other Investing Activity | -12 | 0 | 0 | 0 | 8,190 |
| Investing Cash Flow | $1,970 | $1,993 | $1,641 | $650 | $7,500 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,000 | 4,000 | 2,000 | 1,667 | N/A |
| Debt Repayment | -1,200 | -900 | -600 | -300 | N/A |
| Common Stock Issued | 43 | 42 | 42 | N/A | N/A |
| Other Financing Activity | -1,323 | -1,178 | -627 | -518 | -1,230 |
| Financing Cash Flow | $3,520 | $1,964 | $815 | $849 | $-1,230 |
| Beginning Cash Position | 8,340 | 8,343 | 8,343 | 8,343 | 20,050 |
| End Cash Position | 2,420 | 2,855 | 3,651 | 5,868 | 8,340 |
| Net Cash Flow | $-5,910 | $-5,488 | $-4,692 | $-2,475 | $-11,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,410 | -9,445 | -7,148 | -3,974 | -17,970 |
| Capital Expenditure | -77 | -59 | -9 | N/A | N/A |
| Free Cash Flow | -11,487 | -9,504 | -7,157 | -3,974 | -17,970 |